| |
| |
|
| Insider
Information: |
Richo Anna |
| Relationship: |
Director |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
39,489 |
|
|
Indirect Shares
|
15,479 |
|
|
| Direct
Value |
$11,570,656 |
|
|
|
Indirect Value
|
$3,956,297 |
|
|
| Total
Shares |
54,968 |
|
|
| Total
Value |
$15,526,953 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Amgen Inc |
AMGN |
SVP & CCO |
2012-08-01 |
36,867 |
2012-08-01 |
12,598 |
Premium* |
|
|
Adamas Pharmaceuticals Inc |
ADMS |
Director |
2021-11-24 |
0 |
2020-08-29 |
0 |
Premium* |
|
|
Exelon Corp |
EXC |
Director |
2023-09-30 |
0 |
2024-03-31 |
2,881 |
Premium* |
|
|
Illumina Inc |
ILMN |
Director |
2024-05-16 |
2,622 |
2024-05-16 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
93 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AMGN |
Amgen Inc |
SVP & CCO |
• – – |
2010-07-31 |
4 |
D |
$54.53 |
$50,004 |
D/D |
(917) |
15,844 |
0 |
- |
|
| AMGN |
Amgen Inc |
SVP & CCO |
• – – |
2011-03-11 |
4 |
D |
$51.84 |
$46,812 |
D/D |
(903) |
35,818 |
0 |
- |
|
| AMGN |
Amgen Inc |
SVP & CCO |
• – – |
2011-04-26 |
4 |
D |
$54.69 |
$29,095 |
D/D |
(532) |
41,229 |
0 |
- |
|
| AMGN |
Amgen Inc |
SVP & CCO |
• – – |
2011-04-28 |
4 |
D |
$56.82 |
$29,717 |
D/D |
(523) |
39,788 |
0 |
- |
|
| AMGN |
Amgen Inc |
SVP & CCO |
• – – |
2011-04-29 |
4 |
D |
$57.14 |
$17,713 |
D/D |
(310) |
38,576 |
0 |
- |
|
| AMGN |
Amgen Inc |
SVP & CCO |
• – – |
2011-07-31 |
4 |
D |
$54.70 |
$50,215 |
D/D |
(918) |
37,125 |
0 |
- |
|
| AMGN |
Amgen Inc |
SVP & CCO |
• – – |
2012-03-16 |
4 |
D |
$68.26 |
$159,797 |
D/D |
(2,341) |
39,740 |
0 |
- |
|
| AMGN |
Amgen Inc |
SVP & CCO |
• – – |
2012-04-28 |
4 |
D |
$71.64 |
$47,712 |
D/D |
(666) |
38,083 |
0 |
- |
|
| AMGN |
Amgen Inc |
SVP & CCO |
• – – |
2012-04-29 |
4 |
D |
$71.64 |
$28,226 |
D/D |
(394) |
36,930 |
0 |
- |
|
| AMGN |
Amgen Inc |
SVP & CCO |
• – – |
2012-05-01 |
4 |
D |
$71.11 |
$164,193 |
D/D |
(2,309) |
37,122 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
Director |
– • – |
2021-11-24 |
4 |
D |
$0.00 |
$0 |
D/D |
(25,000) |
0 |
0 |
- |
|
| AMGN |
Amgen Inc |
SVP & CCO |
• – – |
2010-03-12 |
4 |
GA |
$0.00 |
$0 |
I/I |
1,500 |
4,156 |
0 |
- |
|
| AMGN |
Amgen Inc |
SVP & CCO |
• – – |
2010-04-28 |
4 |
GA |
$0.00 |
$0 |
I/I |
902 |
5,058 |
0 |
- |
|
| AMGN |
Amgen Inc |
SVP & CCO |
• – – |
2010-04-29 |
4 |
GA |
$0.00 |
$0 |
I/I |
533 |
5,591 |
0 |
- |
|
| AMGN |
Amgen Inc |
SVP & CCO |
• – – |
2010-07-31 |
4 |
GA |
$0.00 |
$0 |
I/I |
1,583 |
5,607 |
0 |
- |
|
| AMGN |
Amgen Inc |
SVP & CCO |
• – – |
2011-03-14 |
4 |
GA |
$0.00 |
$0 |
I/I |
1,557 |
4,164 |
0 |
- |
|
| AMGN |
Amgen Inc |
SVP & CCO |
• – – |
2011-04-26 |
4 |
GA |
$0.00 |
$0 |
I/I |
918 |
5,082 |
0 |
- |
|
| AMGN |
Amgen Inc |
SVP & CCO |
• – – |
2011-04-28 |
4 |
GA |
$0.00 |
$0 |
I/I |
902 |
5,984 |
0 |
- |
|
| AMGN |
Amgen Inc |
SVP & CCO |
• – – |
2011-04-29 |
4 |
GA |
$0.00 |
$0 |
I/I |
533 |
6,517 |
0 |
- |
|
| AMGN |
Amgen Inc |
SVP & CCO |
• – – |
2011-07-31 |
4 |
GA |
$0.00 |
$0 |
I/I |
1,582 |
7,243 |
0 |
- |
|
| AMGN |
Amgen Inc |
SVP & CCO |
• – – |
2012-01-27 |
4 |
GA |
$0.00 |
$0 |
I/I |
46,446 |
50,189 |
0 |
- |
|
| AMGN |
Amgen Inc |
SVP & CCO |
• – – |
2012-03-16 |
4 |
GA |
$0.00 |
$0 |
I/I |
2,891 |
7,634 |
0 |
- |
|
| AMGN |
Amgen Inc |
SVP & CCO |
• – – |
2012-04-28 |
4 |
GA |
$0.00 |
$0 |
I/I |
759 |
9,166 |
0 |
- |
|
| AMGN |
Amgen Inc |
SVP & CCO |
• – – |
2012-04-29 |
4 |
GA |
$0.00 |
$0 |
I/I |
449 |
9,615 |
0 |
- |
|
| AMGN |
Amgen Inc |
SVP & CCO |
• – – |
2012-05-01 |
4 |
GA |
$0.00 |
$0 |
I/I |
641 |
10,256 |
0 |
- |
|
93 Records found
|
|
Page 2 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
